---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-212607"
form_type: "8-K"
ticker: "OSCR"
cik: "0001568651"
company_name: "Oscar Health, Inc."
filed_at: "2024-09-04T23:59:59+00:00"
generated_at: "2026-05-31T06:26:11.760696+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Oscar Health to reaffirm FY2024 guidance at three investor conferences in Sept 2024

## Summary
- Company participates in Wells Fargo Conference Sept 4, Morgan Stanley Conference Sept 5, and Baird Conference Sept 11.
- Management will reaffirm the updated full-year 2024 guidance from the Q2 2024 earnings release (Aug 7, 2024).
- Presentations webcast; access details on ir.hioscar.com investor relations page.

## SEC filing metadata
- accession: 0001193125-24-212607
- form_type: 8-K
- ticker: OSCR
- cik: 0001568651
- company_name: Oscar Health, Inc.
- filed_at: 2024-09-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1568651/000119312524212607/0001193125-24-212607-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1568651/000119312524212607/d857273d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-212607
- JSON: https://secwatch.observer/filing/0001193125-24-212607.json
- Plain text: https://secwatch.observer/filing/0001193125-24-212607.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.